BSE filing, NSE: M&M. Summary written from the filing by ALFA Finder's alert engine.
Mahindra & Mahindra Ltd: key numbers
- Share price
- ₹2,869.90
- Market cap
- ₹3,56,880 Cr
- Revenue (annual)
- ₹1,98,639 Cr
- Net profit (annual)
- ₹17,099 Cr
- P/E (TTM)
- 19.3×Sector 30.9×
- Promoter holding
- 18.39%-0.06% QoQ
- FII holding
- 33.34%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mahindra & Mahindra Ltd
All →Mahindra & Mahindra Employee Stock Options
Mahindra & Mahindra Limited announced the transfer of equity shares from its Employees' Stock Option Trust to various employees pursuant to the exercise of stock options.
Mahindra & Mahindra Merger & Restructuring
Mahindra & Mahindra's stake in New Democratic Electoral Trust (NDET) reduced to 49.63%, causing NDET to cease being a step-down subsidiary of the Company.
Mahindra & Mahindra Other Announcement
The company filed its quarterly shareholding pattern for the period ending September 30, 2026. This periodic compliance disclosure provides details on promoter and public shareholding.
Mahindra & Mahindra Debt & Borrowing: ₹475 Cr
Mahindra & Mahindra reported on its privately placed Non-Convertible Debentures (NCDs) for the half-year ended 30th September 2026. The company also confirmed full redemption of Rs 475 Crore NCDs.
- Value
- ₹475.0 Cr
Mahindra & Mahindra Merger & Restructuring Worth ₹0.05 Cr
Mahindra & Mahindra is selling a 51% stake in its subsidiary, Novavayu Aerospace Limited, to Embraer S.A. for a consideration of approximately Rs. 0.051 Crore.
- Value
- ₹0.05 Cr
Mahindra & Mahindra Business Update
Mahindra & Mahindra released its monthly production, sales, and export figures for September 2026. The report provides a breakdown by vehicle model and fuel type.
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.